Biotech Archives - Fordham Intellectual Property, Media & Entertainment Law Journal

214

archive,category,category-biotech,category-214,ajax_fade,page_not_loaded,,select-theme-ver-3.3,wpb-js-composer js-comp-ver-5.7,vc_responsive

Biotech

February 20, 2019

Will CBD Companies Finally Get Trademark Protection

...

By Michael Slovak

November 7, 2018

A Face Is Worth a Thousand Words: The Fifth Amendment Implications of The Ability to Unlock Your Phone with Your Face

By Jenny Brejt

October 31, 2018

Government Legislation Calls for Greater Transparency in Drug Pricing

By Tova Dardashty

October 22, 2018

Generic Copaxone Wins in Federal Circuit: Teva’s Patent Loss and Its Immediate Effects

By Raina Duggirala

November 1, 2017

Could CRISPR Patent Pools Foster Biomedical Innovation?

By Anthony Barsamian

October 24, 2017

Among Increasing Outcries for Justice, Pharma Giant Allergan Remains Firm in its Decision to Ignite Change to the IPR System

By Allison Furnari

October 20, 2017

Episode 35: CRISPR, Part II

By Christina Sauerborn

October 13, 2017

Episode 34: CRISPR, Part I

By Christina Sauerborn

October 2, 2013

Generic drugmaker Mylan wins US antitrust approval to buy Agila

By Sarah Haag

June 13, 2013

Isolated Genes are Patent-Ineligible, Apparently

By Tiffany Mahmood